The invention provides new heterocyclic compounds having the general formula (le), wherein R1, R1a and R7 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds. The compounds of formula (le) are monoacylglycerol lipase (MAGL) inhibitors, for use in the treatment of a variety of disorders.
这项发明提供了具有一般式(Ie)的新
杂环化合物,其中R1、R1a和R7如本文所述,包括这些化合物的组合物,制造这些化合物的方法以及使用这些化合物的方法。式(Ie)的化合物是单酰基
甘油酶(MAGL)
抑制剂,用于治疗各种疾病。